STAT News

STAT+: Pharmalittle: We’re reading about the 340B drug pilot program, an obesity drug disappointment, and more

The U.S. approved 10 drugmakers to participate in a 340B pilot program that will allow them to offer rebates, instead of upfront discounts, to certain providers

Por STAT News

1 minuto de lectura
Compartir
STAT+: Pharmalittle: We’re reading about the 340B drug pilot program, an obesity drug disappointment, and more
STAT+: Pharmalittle: We’re reading about the 340B drug pilot program, an obesity drug disappointment, and more

¿Tiene noticias que compartir con el sector de eventos?

Envíe un comunicado de prensa o una noticia y llegue a miles de profesionales del sector de eventos.

Contáctenos→

Más en Health Tech

Perspectivas relacionadas